RSP Systems raises millions for launch of non-invasive blood glucose meter
The Danish medtech company RSP Systems has secured nearly DKK 50 million through fundraising. However, the goal is to raise three times as much in order to launch a non-invasive blood glucose meter in Europe by the beginning of 2020, according to the company's CSO and former CEO.
The medtech company RSP Systems, which was founded in 2006 as a spin-out from University of Southern Denmark (SDU), has just closed the first part of a Series B financing round and has secured nearly DKK 50 million (USD 7.9 million) for the continued operations of the company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
